神林 祐子

Disproportionality Analysis of Pulmonary Adverse Events Associated with Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report Database 

Clinical Drug Investigation 45(11) 901-907 2025年11月  

Efficacy of compression therapy for prevention of peripheral neuropathy caused by taxane-based chemotherapy: a single-center retrospective observational study. 

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 33(6) 478-478 2025年5月17日  筆頭著者責任著者

Factors Contributing to Blood Glucose Elevation Associated With Olanzapine Used as an Antiemetic During Cancer Chemotherapy. 

In vivo (Athens, Greece) 39(2) 902-908 2025年  筆頭著者責任著者

Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER. 

In vivo (Athens, Greece) 39(1) 360-366 2025年  査読有り筆頭著者責任著者

Evaluation of Lung Adverse Events Associated With Lenvatinib: A Post-marketing Surveillance Study. 

In vivo (Athens, Greece) 39(1) 346-352 2025年  査読有り筆頭著者責任著者

Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database. 

British journal of clinical pharmacology 90(12) 3348-3354 2024年9月2日  査読有り筆頭著者責任著者

ペムブロリズマブによる心臓関連有害事象の発症時期と転帰の評価:日本の市販後調査データを用いた解析 

日本薬学会年会要旨集(Web) 32(1) 279-287 2024年6月  査読有り筆頭著者責任著者

Predictors for the development of thromboembolic events in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis. 

Oncology 2024年1月10日  査読有り筆頭著者責任著者

Evaluation of time to onset and outcome of cardiac adverse events associated with nilotinib using post-marketing surveillance. 

Oncology 2023年8月18日  査読有り筆頭著者責任著者

Evaluation of time to onset and outcome of lung adverse events related to pembrolizumab using marketing surveillance. 

Oncology 2023年8月17日  査読有り筆頭著者責任著者

Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan. 

Scientific reports 13(1) 8819-8819 2023年5月31日  査読有り筆頭著者責任著者

Risk factors of capecitabine-induced hand-foot syndrome: a single-institution, retrospective study. 

Oncology 2023年4月19日  査読有り筆頭著者責任著者

Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database. 

Clinical drug investigation 43(3) 177-184 2023年2月13日  査読有り筆頭著者責任著者

Evaluation of Cardiac Adverse Events with Ponatinib Using a Spontaneous Reporting Database. 

Oncology 101(6) 397-405 2023年  査読有り筆頭著者責任著者

Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database. 

Medical oncology (Northwood, London, England) 39(12) 219-219 2022年9月29日  査読有り筆頭著者責任著者

Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database. 

Scientific reports 12(1) 15619-15619 2022年9月16日  査読有り筆頭著者責任著者